Pricey Weed Stocks: A Lesson From Cheap Oil

The wild prices and IPOs of the oil bubble should have made investors sceptical of stocks such as Canopy Growth (NYSE:CGC)(TSX:WEED), yet they continue to overlook familiar trends.

| More on:

When West Texas Intermediate danced around US$100 per barrel, the energy sector could do no wrong. From 2011 to 2014, the market was awash with oil and gas IPOs, mergers and acquisitions, risky debt, and inflated share prices.

The sales pitch was all about the amount of the hot commodity that any given company could produce. Broadly speaking, margins were strong and investors were buying stocks based on how quickly companies could get oil out of the ground.

When the party was over, however, it turned out that it wasn’t all about quantity — it was about costs. Disciplined energy companies that pursued projects with the best economics are still alive and well today.

Unfortunately, producers that succumbed to exuberance paid the price. Often laden with debt and running a loss on every barrel, companies took write-downs on reserves that had become worthless and many closed their doors entirely.

But, you might well ask, what does this have to do with marijuana stocks?

Surely demand for cannabis must continue to outstrip supply, supporting market prices?

Surely margins are outstanding and weed companies should soon be rolling in profits?

Well, maybe not.

In the interest of making the connection between the two themes I’m discussing, we will use Canopy Growth (NYSE:CGC)(TSX: WEED) purely illustratively.

The emphasis on capacity

Open up the management’s discussion and analysis documents for pretty much any weed company’s latest quarter and a few things are going to repeat themselves again and again: expansion, production, capacity, and heaps of figures about greenhouse square footage.

It’s déjà vu all over again.

Several short years ago we were reading nearly identical documents talking about ramping up production of barrels of oil equivalent per day, newly purchased hectares of land, and probable reserves.

When I read speculative numbers about supply and very little mention of material sales, it gives me the goodwill and intangibles chills; it makes me wonder whether it will all go up in smoke.

Consider the following sentence about the value of their inventory in Canopy’s report for the year-ended March 31, 2019: “Because there is no actively traded commodity market for [cannabis] plants or dried product, the valuation of these biological assets is obtained using valuation techniques where the inputs are based upon unobservable market data”.

To me that reads like somebody just handed himself or herself a degree in creative accounting.

Show me the margins

Your local drug dealer wouldn’t sell marijuana if it weren’t profitable. Period.

Conversely, weed companies have been continuously selling their investors on the notion that the next variation on their product will be the one that makes it all worthwhile.

First, there was the promise of making big bucks from Health Canada and medicinal marijuana.

Next, the dough was going to come from recreational dried plant.

Hold on, CBD is where the ball really gets rolling.

Don’t worry: money-maker edibles will be legal in the fall.

What’s next, folks?

Year over year, Canopy’s fourth-quarter overall average sale price fell around 11% to about $7.49 a gram. Further, the decline in the fair value of its biological assets amounted to just over $77 million in Q4 alone.

Gross margin before fair value impacts in cost of sales – what a mouthful – is a non-IFRS accounting measure for a reason.

The teachings of black gold

All of the above is to say that commodities, be it oil, gold, or weed, fluctuate in value and tend to go through periods of intense investor interest.

The problem, then, is finding disciplined producers that can keep costs under control and focus upon sustainably increasing shareholder value over the long run.

When doing your research on marijuana stocks, don’t forget the lessons that we learned from oil.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor James Watkins-Strand has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »